A carregar...
Identification of LAMC2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies. While the extracellular matrix (ECM) components plays an integral role in PDAC pathogenesis and mediating chemoresistance, its role in predicting response to chemotherapy in PDAC patients remains unclear. MET...
Na minha lista:
| Publicado no: | Eur J Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7940597/ https://ncbi.nlm.nih.gov/pubmed/33607476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2020.12.031 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|